DSpace Repository

The interplay of triphala and its constituents with respect to metabolic disorders and gut-microbiome

Show simple item record

dc.contributor.author Taliyan, Rajeev
dc.date.accessioned 2025-11-11T08:55:48Z
dc.date.available 2025-11-11T08:55:48Z
dc.date.issued 2025-07
dc.identifier.uri https://www.sciencedirect.com/science/article/pii/S0367326X25002679
dc.identifier.uri http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/20017
dc.description.abstract Ayurveda is based on natural therapeutic methods that focuses on eliminating toxins from the body and enhancing both physical and mental regeneration using herbal remedies. Medicinal plants have significant elemental and therapeutic value. Triphala (TLP) is a highly potent polyherbal Ayurvedic remedy that is widely regarded as one of the most crucial ayurvedic supplements. This study aims to analyze and comprehend the effectiveness and therapeutic value of TLP and its components by summarizing the pertinent literature based on a selection of publications obtained through a focused search of reliable academic resources. The review primarily emphasizes on the ethnomedical and pharmacological effects of TLP, while also providing a probable explanation of the underlying molecular mechanism. TLP is recognized for its antioxidant, anti-inflammatory, immunomodulatory, antibacterial, antimutagenic, hypoglycemic, antineoplastic, chemoprotective, and radioprotective properties. It is also effective against parasitic infections, and other infectious disorders. Although, the mechanisms are not well explored but these activities are also ascribed to alter the gut microbiota composition. Therefore, it is imperative to undertake rigorous systematic study for TLP in order to identify and assess the chemical ingredients which bring about the change either in gut microbiome composition or increase the number of beneficial gut-microbiota. Hence, this review thoroughly examines the pharmacological advantages of Triphala with special emphasis on molecular mechanisms altering the gut-microbiota prior to its potential utilization in clinical environments. en_US
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.subject Pharmacy en_US
dc.subject Triphala en_US
dc.subject Ayurvedic medicine en_US
dc.subject Terminalia chebula en_US
dc.subject Terminalia bellerica en_US
dc.subject Microbiome en_US
dc.subject Phytochemical ingredients en_US
dc.title The interplay of triphala and its constituents with respect to metabolic disorders and gut-microbiome en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account